Yeji
PDUFAoutcome: unknownconf 0.99

beremagene geperpavec — PDUFA

$KRYS · Krystal Biotech, Inc. · Dystrophic Epidermolysis Bullosa
Event date
February 17, 2023
1205 days ago
Sponsor runway
cash-flow +
$501.3M liquid

Evidence

“The application has been granted Priority Review designation and the FDA has set a Prescription Drug User Fee Act action date of February 17, 2023.”
Source: 8-K filed 2022-08-18View on EDGAR ↗0001711279-22-000052

Comparable historical pdufas· last 5 years · same indication

TickerDrugDateOutcome
$KRYSberemagene geperpavec2023-05-19unknown

Recent insider activity· ±90 days

7 insiders · 0 buys · 51 sells
Sell10b5-1
2023-05-09
JANNEY DANIEL
Director
17,100 @ $90.74$1.55M
Sell10b5-1
2023-04-19
JANNEY DANIEL
Director
7,900 @ $90.32$713K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
4,297 @ $86.80$373K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
500 @ $89.12$45K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
9,429 @ $87.41$824K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
9,724 @ $88.41$860K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
4,298 @ $86.80$373K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
9,428 @ $87.41$824K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
1,050 @ $85.55$90K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
4,298 @ $86.80$373K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
9,428 @ $87.41$824K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
9,724 @ $88.41$860K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
500 @ $89.12$45K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
9,429 @ $87.41$824K
Sell10b5-1
2023-04-17
Krishnan Krish S
President and CEO
4,297 @ $86.80$373K
Sell10b5-1
2023-04-17
Krishnan Suma
President, R&D
1,050 @ $85.55$90K
Grant
2023-03-31
Mazzacco Catherine
Director
13,600 @ ——
Sell
2023-03-01
ROSSI DINO A
Director
40,000 @ $83.25$3.33M
Grant
2023-02-28
Krishnan Krish S
President and CEO
50,000 @ $81.91$4.10M
Grant
2023-02-28
ORTH ANDREW C.
Chief Commercial Officer
20,000 @ ——
Grant
2023-02-28
ORTH ANDREW C.
Chief Commercial Officer
10,000 @ ——
Grant
2023-02-28
Krishnan Suma
President, R&D
30,000 @ ——
Grant
2023-02-28
Krishnan Suma
President, R&D
15,000 @ ——
Grant
2023-02-28
Krishnan Krish S
President and CEO
25,000 @ ——
Grant
2023-02-28
ROMANO KATHRYN
Chief Accounting Officer
20,000 @ ——
Grant
2023-02-28
ROMANO KATHRYN
Chief Accounting Officer
10,000 @ ——
Tax
2023-02-26
ROMANO KATHRYN
Chief Accounting Officer
2,144 @ $78.46$168K
Tax
2023-02-26
Krishnan Suma
President, R&D
3,057 @ $78.46$240K
Tax
2023-02-26
Krishnan Krish S
President and CEO
4,350 @ $78.46$341K
Sell
2023-01-18
Krishnan Suma
President, R&D
2,048 @ $80.75$165K
Sell
2023-01-18
Krishnan Suma
President, R&D
803 @ $81.56$65K
Sell
2023-01-18
Krishnan Krish S
President and CEO
804 @ $81.56$66K
Sell
2023-01-18
Krishnan Krish S
President and CEO
2,048 @ $80.75$165K
Sell
2023-01-18
Krishnan Krish S
President and CEO
803 @ $81.56$65K
Sell
2023-01-18
Krishnan Suma
President, R&D
804 @ $81.56$66K
Sell
2023-01-17
Krishnan Krish S
President and CEO
1,186 @ $81.41$97K
Sell
2023-01-17
Krishnan Suma
President, R&D
20,617 @ $80.70$1.66M
Sell
2023-01-17
Krishnan Suma
President, R&D
1,186 @ $81.41$97K
Sell
2023-01-17
Krishnan Suma
President, R&D
345 @ $82.72$29K
Sell
2023-01-17
Krishnan Suma
President, R&D
346 @ $82.71$29K
Sell
2023-01-17
Krishnan Krish S
President and CEO
20,617 @ $80.70$1.66M
Sell
2023-01-17
Krishnan Krish S
President and CEO
346 @ $82.71$29K
Sell
2023-01-17
Krishnan Krish S
President and CEO
345 @ $82.72$29K
Sell
2023-01-04
Krishnan Krish S
President and CEO
3,938 @ $80.09$315K
Sell
2023-01-04
Krishnan Suma
President, R&D
3,938 @ $80.09$315K
Sell
2023-01-04
Krishnan Suma
President, R&D
3,748 @ $80.08$300K
Sell
2023-01-04
Krishnan Krish S
President and CEO
3,748 @ $80.08$300K
Sell
2023-01-03
Krishnan Suma
President, R&D
1,700 @ $80.33$137K
Sell
2023-01-03
Krishnan Krish S
President and CEO
1,700 @ $80.33$137K
Sell
2022-12-29
Krishnan Krish S
President and CEO
528 @ $81.10$43K
+ 13 more
← All catalysts for $KRYS